Inventurus Knowledge Solutions Limited (IKS) has successfully completed the acquisition of 100% of the shareholding in its wholly-owned material subsidiary, Inventurus Knowledge Solutions Inc. (IKS Inc.). IKS Inc., in turn, acquired Turbo Health Holdings, LLC, a U.S.-based company operating in the healthcare technology sector, for a total consideration of USD 500,000. The acquisition aims to expand IKS’s market reach and enhance its complementary capabilities in the ambulatory revenue cycle management business.
IKS Completes Strategic Acquisition
Inventurus Knowledge Solutions Limited (IKS) announced today the completion of a significant acquisition that will bolster its presence in the healthcare technology market. The company’s U.S.-based wholly-owned subsidiary, Inventurus Knowledge Solutions Inc. (IKS Inc.), has acquired 100% of the shareholding in Turbo Health Holdings, LLC (the “Target”). This strategic move, finalized on November 10, 2026, underscores IKS’s commitment to expanding its service offerings and market penetration.
Deal Rationale and Financials
The acquisition was approved by the Board of Directors of IKS Inc. and involved a total cash consideration of USD 500,000. Turbo Health Holdings, LLC is a newly incorporated entity engaged in the healthcare technology segment, specifically within the ambulatory revenue cycle management (RCM) business. The acquisition represents an important opportunity to expand IKS’s market reach, leveraging the Target’s complementary capabilities and relationships to deliver greater value to healthcare organizations and clients.
Synergies and Future Impact
IKS highlighted that the acquisition is expected to strengthen the organization’s solutions and enhance its competitive position in the industry. The Target entity, Turbo Health Holdings, LLC, primarily comprises certain transferred client contracts from Optum Insight. Its business line is focused on healthcare technology and IT services/software industry. This transaction is not considered a related-party transaction, and the promoter/promoter group of the Company does not have any interest in the acquired entity, ensuring the deal was conducted at arm’s length.
Source: BSE
